Can anorexia cause fatty liver disease? Yes, anorexia nervosa can lead to hepatic steatosis (fatty liver), though this may seem unexpected given the condition's association with severe caloric restriction. During prolonged starvation, the body mobilises fat from adipose tissue, overwhelming the liver's capacity to process and export these fats. Malnutrition impairs the synthesis of proteins needed for fat transport, causing triglycerides to accumulate in liver cells. This article explores the mechanisms behind anorexia-related fatty liver, how to recognise liver problems, treatment approaches, and when to seek urgent medical help.

Can Anorexia Cause Fatty Liver Disease?

Anorexia nervosa can indeed lead to fatty liver disease, though this may seem counterintuitive given the condition's association with severe caloric restriction and low body weight. The development of hepatic steatosis (fatty liver) in anorexia occurs through several distinct mechanisms that differ from the obesity-related pathway typically associated with non-alcoholic fatty liver disease (NAFLD).

During prolonged starvation, the body mobilises fat stores from adipose tissue to meet energy demands. This process releases free fatty acids into the bloodstream, which are then transported to the liver for processing. However, severe malnutrition impairs the liver's ability to synthesise the proteins and lipoproteins necessary to export these fats back into circulation. Consequently, triglycerides accumulate within hepatocytes, resulting in hepatic steatosis. Additionally, the liver's capacity to undergo beta-oxidation (fat breakdown for energy) becomes compromised due to nutritional deficiencies, particularly of essential amino acids and vitamins. Severe starvation can also cause direct hepatocellular injury through processes such as autophagy and ischaemia-like changes, which may contribute to elevated liver enzymes independently of fat accumulation.

Key mechanisms include:

• Increased peripheral lipolysis overwhelming hepatic processing capacity

• Impaired synthesis of very-low-density lipoproteins (VLDL) needed for fat export

• Deficiencies in choline, essential amino acids, and other nutrients required for normal liver metabolism

• Mitochondrial dysfunction affecting fatty acid oxidation

• Direct hepatocellular injury from starvation-induced autophagy and metabolic stress

The severity of liver involvement in anorexia nervosa varies considerably between individuals. Estimates of hepatic steatosis prevalence vary widely depending on the population studied and detection methods used, though robust population-based data are limited. Importantly, the liver changes associated with anorexia are generally reversible with appropriate nutritional rehabilitation, distinguishing this condition from other forms of chronic liver disease. However, without treatment, progressive malnutrition can lead to more serious hepatic complications, including elevated liver enzymes, hepatomegaly, and in rare cases, severe hepatic dysfunction. Marked transaminase elevations can occur both during profound starvation and during early refeeding, though acute liver failure is extremely rare.

Recognising Liver Problems in Anorexia

Identifying liver dysfunction in patients with anorexia nervosa requires clinical vigilance, as symptoms may be subtle or attributed to the eating disorder itself. Many individuals with anorexia-related hepatic steatosis remain asymptomatic, with liver abnormalities detected only through routine blood tests or imaging studies. However, certain clinical features should prompt investigation of liver health.

Common presentations include:

• Elevated liver enzymes (transaminases) on blood tests, particularly alanine aminotransferase (ALT) and aspartate aminotransferase (AST)

• Right upper quadrant abdominal discomfort or a sensation of fullness

• Hepatomegaly (enlarged liver) detected on physical examination

• Jaundice (yellowing of skin and eyes) in more severe cases, though this is uncommon

• Fatigue and malaise, which may be difficult to distinguish from symptoms of malnutrition itself

Blood investigations typically reveal a hepatocellular pattern of liver enzyme elevation, with ALT and AST levels ranging from mildly to moderately increased (usually 2–5 times the upper limit of normal). Enzyme patterns can vary in starvation, and whilst the AST:ALT ratio may be less than 1 in some cases, this ratio alone should not be used to distinguish anorexia-related liver changes from other causes. Alkaline phosphatase (ALP) may be within normal ranges or low in malnutrition due to reduced bone turnover; elevated ALP may suggest cholestasis or other pathology. Bilirubin levels usually remain within normal ranges unless liver dysfunction is severe. Importantly, serum albumin is often normal in anorexia nervosa; low albumin levels may indicate intercurrent illness, inflammation, severe disease, or fluid shifts rather than simple malnutrition.

It is essential to exclude alternative causes of abnormal liver function tests. Clinicians should take a careful history of alcohol use, medications, and herbal or dietary supplements, and consider investigations including viral hepatitis serology (hepatitis B and C), autoimmune liver screen (antinuclear antibodies, anti-smooth muscle antibodies, immunoglobulins), iron studies and ferritin, coeliac serology where relevant, and in young patients, screening for Wilson's disease (serum caeruloplasmin and copper). Ultrasound or other imaging may help exclude gallstone disease and structural abnormalities.

According to NICE guidance on eating disorders (NG69), baseline liver function tests should be performed as part of the initial medical assessment for anorexia nervosa, with regular monitoring during treatment. The frequency of monitoring depends on the severity of malnutrition and medical risk, as outlined in the Royal College of Psychiatrists' Medical Emergencies in Eating Disorders (MEED) guidance. Ultrasound imaging may demonstrate increased hepatic echogenicity consistent with fatty infiltration, though this finding is non-specific. More advanced imaging techniques, such as transient elastography (FibroScan) or MRI, can quantify liver fat content and assess for fibrosis, though these are typically reserved for cases where significant liver disease is suspected. Clinicians should maintain a low threshold for investigating liver function, particularly in patients with severe or prolonged malnutrition, rapid weight loss, or those beginning nutritional rehabilitation.

Treatment and Recovery for Liver Health

The cornerstone of treating anorexia-related fatty liver disease is careful nutritional rehabilitation under specialist supervision. Unlike fatty liver disease associated with obesity, where weight loss is therapeutic, patients with anorexia require gradual, monitored weight restoration to reverse hepatic steatosis. This process must be undertaken cautiously to avoid refeeding syndrome, a potentially life-threatening complication that can occur when nutrition is reintroduced too rapidly after prolonged starvation.

Nutritional rehabilitation must be individualised and risk-stratified according to UK guidance (NICE CG32 on nutrition support in adults and the Royal College of Psychiatrists' MEED 2022 guidance). Energy prescriptions are based on clinical risk assessment rather than fixed calorie targets. For patients at high risk of refeeding syndrome (e.g., very low body mass index, negligible recent intake, rapid weight loss, or electrolyte disturbances), initial energy intake may start at approximately 5–10 kcal/kg/day, with careful incremental increases guided by clinical and biochemical monitoring. Lower-risk patients may tolerate higher starting intakes, but all prescriptions must be determined by specialist eating disorder teams to balance the need for nutritional restoration against refeeding risk.

Nutritional rehabilitation involves:

• Risk-stratified energy prescription (kcal/kg/day) determined by specialist dietitians and medical teams

• Balanced macronutrient distribution with adequate protein to support hepatic protein synthesis, tailored to individual clinical needs

• Prophylactic thiamine supplementation (typically 200–300 mg/day orally, or intravenously if indicated) plus a comprehensive multivitamin and mineral supplement before and during refeeding

• Prophylactic supplementation and close monitoring of electrolytes, particularly phosphate, potassium, and magnesium

• Daily monitoring of electrolytes, fluid balance, ECG, and clinical status during early refeeding, with immediate escalation if abnormalities occur

• Involvement of specialist dietitians experienced in eating disorder management

Medical monitoring during nutritional rehabilitation is essential. Paradoxically, liver enzymes may initially rise further during early refeeding before improving, a phenomenon thought to relate to hepatocyte regeneration and metabolic reactivation. This transient elevation can occur over days to weeks but requires serial monitoring to ensure progressive improvement. Clinicians should be alert for signs of refeeding syndrome, including hypophosphataemia, hypokalaemia, hypomagnesaemia, fluid retention, and cardiac arrhythmias, which require immediate intervention and may necessitate adjustment of feeding regimens.

There is no specific pharmacological treatment for anorexia-related fatty liver disease. Hepatoprotective agents occasionally used in other forms of liver disease have not been proven beneficial in this context. The focus remains on addressing the underlying eating disorder through a multidisciplinary approach involving psychiatry, psychology, dietetics, and medical specialties. As nutritional status improves and weight is restored, hepatic steatosis typically resolves completely over several weeks to months. Follow-up liver function tests should demonstrate progressive normalisation, though this may take 3–6 months or longer depending on the severity of initial malnutrition. Patients should be reassured that with appropriate treatment, liver recovery is expected, providing strong motivation for engagement with eating disorder services.

When to Seek Medical Help

Individuals with anorexia nervosa or their families should seek medical attention promptly if certain warning signs develop, as these may indicate significant liver dysfunction or other serious complications of malnutrition. Early intervention can prevent progression to more severe hepatic injury and facilitate appropriate specialist referral.

Call 999 or attend the nearest Emergency Department immediately if:

• Severe confusion, drowsiness, or altered mental state occurs

• Collapse or loss of consciousness

• Severe abdominal pain, particularly if associated with rigidity or signs of peritonism

• Uncontrolled bleeding or signs of sepsis (high fever, rapid heart rate, feeling very unwell)

• Suspected refeeding syndrome during nutritional rehabilitation

Seek urgent medical assessment (same day or next day) if:

• Jaundice develops (yellowing of the skin or whites of the eyes)

• Easy bruising or bleeding occurs, which may indicate impaired liver synthetic function

• Dark urine or pale stools are noticed

• Rapid weight loss accelerates or body mass index (BMI) falls below 15 kg/m²

• Marked bradycardia (very slow heart rate), hypotension (low blood pressure), or hypothermia (low body temperature) is detected

Routine medical monitoring is essential for all individuals with anorexia nervosa, even in the absence of acute symptoms. NICE recommends (NG69) that patients with eating disorders should have regular physical health assessments, including cardiovascular examination, blood tests (full blood count, urea and electrolytes, liver function, bone profile, and glucose), and ECG monitoring. The frequency of monitoring depends on the severity of the condition, with more intensive surveillance required for those with severe malnutrition (BMI <15 kg/m²), rapid weight loss, or other medical risk factors as outlined in the MEED 2022 guidance.

Patients already engaged with eating disorder services should report any new symptoms to their care team, including unexplained fatigue, abdominal discomfort, or changes in appetite. Those not currently receiving specialist care should contact their GP to discuss referral to local eating disorder services. In England and Wales, community eating disorder services for adults are available through NHS mental health trusts, whilst children and adolescents can access Child and Adolescent Mental Health Services (CAMHS) eating disorder teams. In Scotland, access is via NHS 24 (call 111) or local mental health services, and in Northern Ireland, via local Health and Social Care (HSC) trusts.

Contact your GP if:

• You have concerns about eating patterns, weight loss, or restrictive eating behaviours

• Blood tests have shown abnormal liver function

• You are experiencing symptoms that may relate to malnutrition

• You need support accessing specialist eating disorder services

If jaundice, coagulopathy (abnormal clotting), encephalopathy (confusion due to liver failure), or rapidly rising liver enzymes occur, urgent hepatology input should be sought to exclude alternative liver pathology and guide management. Family members and carers play a vital role in recognising deterioration and facilitating access to appropriate care. If immediate medical attention is required and the GP is unavailable, patients should call 999 for life-threatening symptoms, attend the nearest Emergency Department, or call NHS 111 (England, Wales, Scotland) or the local out-of-hours service for advice. Early identification and treatment of both the eating disorder and its medical complications, including liver involvement, significantly improve long-term outcomes and reduce the risk of serious harm.

Frequently Asked Questions